Surgalign Holdings Inc SRGA shares are trading higher by 13.2% at $1.02 Monday morning. CEO Terry Rich reported the purchase of 1,078,701 shares at an average price of $0.93 per share in a Form 4 filing on Friday.
Surgalign last week reported quarterly losses of 5 cents per share which beat the analyst consensus estimate of a loss of 12 cents per share by 58.33 percent. The company also reported quarterly sales of $24.80 million which met the analyst consensus estimate.
Surgalign is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes.
Surgalign has a 52-week high of $3.27 and a 52-week low of $0.88.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
